Vera Therapeutics (VERA)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Nephrologysrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 19/100 (LOW), 27.1 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 33.12% of float, squeeze risk: HIGH
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Do Vera Therapeutics' (VERA) High-Profile IgAN Data Show Durable Moat or Crowded Mechanism Risk?
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
- Vera Therapeutics (VERA) Says TRUTAKNA Met All Phase III Endpoints
- Vera Reverses Its Major Chart Upset As Vertex Rivalry Deepens — What Happened?
- Vera set up for full approval for Trutakna in IgAN with Phase III win
- Vera Therapeutics Shares Rise 13% After TRUTAKNA Meets ORIGIN 3 Trial Endpoints
- Sector Update: Healthcare Stocks Fall Pre-Bell Tuesday
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Rusfertide for Polycythemia Vera: Incremental Benefit Assessment. — Am J Hematol 2026 Oct 17 PMID 42891571
- Aloe Vera Gel Compared to Cold/Warm Compresses for Reducing Ecchymosis at the Saphenous Vein Graft Harvest Site: Randomized Controlled Clinical Trial. — Iran J Nurs Midwifery Res 2026 Sep-Oct PMID 42866774
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Vera Therapeutics.
Full VERA Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.